Literature DB >> 11108651

Associations of clinical features in neurofibromatosis 1 (NF1).

J Szudek1, P Birch, V M Riccardi, D G Evans, J M Friedman.   

Abstract

Neurofibromatosis 1 (NF1), an autosomal dominant disease, exhibits extreme clinical variability. This variability greatly increases the burden for affected families and impairs our ability to understand the pathogenesis of NF1. Recognition of heterogeneity within a disease may provide important pathogenic insights, therefore we tested clinical data from three large sets of NF1 patients for evidence that certain common features are more likely to occur in some NF1 patients than in others. Clinical information on 4,402 patients with NF1 was obtained from three independent databases. We examined associations between pairs of clinical features in individual affected probands. We also examined associations between the occurrence of individual features in affected relatives. Associations were summarized as odds ratios with 95% confidence intervals. We found associations between several pairs of features in affected probands: intertriginous freckling and Lisch nodules, discrete neurofibromas and plexiform neurofibromas, discrete neurofibromas and Lisch nodules, plexiform neurofibromas and scoliosis, learning disability or mental retardation and seizures. We also found associations between the occurrence of Lisch nodules, macrocephaly, short stature, and learning disability or mental retardation as individual features in parents and children with NF1. Our observations suggest that, contrary to established belief, some NF1 patients are more likely than others to develop particular manifestations of the disease. Genetic factors appear to determine the development of particular phenotypic features. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 11108651     DOI: 10.1002/1098-2272(200012)19:4<429::AID-GEPI13>3.0.CO;2-N

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  20 in total

1.  Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.

Authors:  Lu Q Le; Tracey Shipman; Dennis K Burns; Luis F Parada
Journal:  Cell Stem Cell       Date:  2009-05-08       Impact factor: 24.633

2.  CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.

Authors:  Wei Mo; Jian Chen; Amish Patel; Liang Zhang; Vincent Chau; Yanjiao Li; Woosung Cho; Kyun Lim; Jing Xu; Alexander J Lazar; Chad J Creighton; Svetlana Bolshakov; Renée M McKay; Dina Lev; Lu Q Le; Luis F Parada
Journal:  Cell       Date:  2013-02-21       Impact factor: 41.582

3.  Characterization of early communicative behavior in mouse models of neurofibromatosis type 1.

Authors:  Susan E Maloney; Krystal C Chandler; Corina Anastasaki; Michael A Rieger; David H Gutmann; Joseph D Dougherty
Journal:  Autism Res       Date:  2017-08-26       Impact factor: 5.216

Review 4.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

5.  Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1.

Authors:  Emre Cecen; Dilek Ince; Kamer Mutafoglu Uysal; Erdener Ozer; Riza Cetingoz; Ali Aykan Ozguven; Handan Cakmakci; Faik Sarialioglu; Nur Olgun
Journal:  Childs Nerv Syst       Date:  2011-03-26       Impact factor: 1.475

6.  Monozygotic twins discordant for neurofibromatosis 1.

Authors:  Lee Kaplan; Rosemary Foster; Yiping Shen; Dilys M Parry; Mary L McMaster; Melanie Collins O'Leary; James F Gusella
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

7.  Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.

Authors:  Lu Q Le; Chiachi Liu; Tracey Shipman; Zhiguo Chen; Ueli Suter; Luis F Parada
Journal:  Cancer Res       Date:  2011-05-06       Impact factor: 12.701

8.  Racial/ethnic disparities and incidence of malignant peripheral nerve sheath tumors: results from the Surveillance, Epidemiology, and End Results Program, 2000-2014.

Authors:  Erin C Peckham-Gregory; Roberto E Montenegro; David A Stevenson; David H Viskochil; Michael E Scheurer; Philip J Lupo; Joshua D Schiffman
Journal:  J Neurooncol       Date:  2018-04-16       Impact factor: 4.130

9.  Epilepsy in NF1: a systematic review of the literature.

Authors:  Pia Bernardo; Giuseppe Cinalli; Claudia Santoro
Journal:  Childs Nerv Syst       Date:  2020-07-01       Impact factor: 1.475

10.  Genetic counseling throughout the life cycle.

Authors:  Leslie J Ciarleglio; Robin L Bennett; Jennifer Williamson; Jessica B Mandell; Joan H Marks
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.